Annals of Surgical Oncology

, Volume 22, Issue 2, pp 528–534 | Cite as

Proposal of New Classification for Stage III Colon Cancer Based on the Lymph Node Ratio: Analysis of 4,172 Patients from Multi-Institutional Database in Japan

  • Kiichi Sugimoto
  • Kazuhiro Sakamoto
  • Yuichi Tomiki
  • Michitoshi Goto
  • Kenjiro Kotake
  • Kenichi Sugihara
Colorectal Cancer

Abstract

Background

We retrospectively examined the optimal lymph node ratio (LNR) cutoff value and attempted to construct a new classification using the LNR in stage III colon cancer.

Methods

The clinical and pathological data of 4,172 patients with histologically proven lymph node metastasis who underwent curative surgery for primary colon cancer at multiple institutions between 1995 and 2004 were derived from the multi-institutional database of the Japanese Society for Cancer of the Colon and Rectum (JSCCR). We determined independent prognostic factors and constructed a new classification using these factors. Finally, we compared the discriminatory ability between the new classification and the TNM seventh edition (TNM 7th) classification.

Results

The optimal LNR cutoff value was 0.18. Multivariate analysis revealed that year of surgery, age, gender, histological type, TNM 7th T category, lymphatic invasion, venous invasion, TNM 7th N category, and LNR were found to be significant independent prognostic factors. We attempted to construct a new classification based on the combination of TNM 7th T category and LNR. As a result, the cancer-specific survivals were well stratified (P < .0001). According to the Akaike’s information criteria value, the new classification was judged to be superior to the TNM 7th classification with respect to both a better fit and lower complexity.

Conclusions

The optimal LNR cutoff value that was found using the Japanese multi-institutional database and the new classification using LNR are considered to be extremely significant. Therefore, these findings strongly support the application of LNR in the stage classification in stage III colon cancer.

Keywords

Metastatic Lymph Node Lymph Node Ratio Tumor Node Metastasis Postoperative Adjuvant Chemotherapy Tumor Node Metastasis Classification 

Notes

Acknowledgment

The authors thank Dr. Joe Matsuoka (Juntendo University, Graduate School of Medicine, Clinical Research Center) for assistance in the statistical analysis of the data.

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Dukes CE, Bussey HJ. The spread of rectal cancer and its effect on prognosis. Br J Cancer. 1958;12:309–20.PubMedCentralPubMedCrossRefGoogle Scholar
  2. 2.
    Chapuis PH, Dent OF, Bokey EL, Newland RC, Sinclair G. Adverse histopathologic findings as a guide to patient management after curative resection of node-positive colonic cancer. Br J Surg. 2004;91:349–54.PubMedCrossRefGoogle Scholar
  3. 3.
    Kotake K, Honjo S, Sugihara K, Hashiguchi Y, Kato T, Kodaira S, et al. Number of lymph nodes retrieved is an important determinant of survival of patients with stage II and stage III colorectal cancer. Jpn J Clin Oncol. 2012;42:29–35.PubMedCrossRefGoogle Scholar
  4. 4.
    Resch A, Langner C. Lymph node staging in colorectal cancer: old controversies and recent advances. World J Gastroenterol. 2013;19:8515–26.PubMedCentralPubMedCrossRefGoogle Scholar
  5. 5.
    Cunningham D, Atkin W, Lenz HJ, Lynch HT, Minsky B, Nordlinger B, et al. Colorectal cancer. Lancet. 2010;375:1030–47.PubMedCrossRefGoogle Scholar
  6. 6.
    Sobin LH, Gaspodarowicz M, Wittekind C. TNM classification of malignant tumours. 7th ed. New York: Wiley-Blackwell, 2009.Google Scholar
  7. 7.
    Ceelen W, Van Nieuwenhove Y, Pattyn P. Prognostic value of the lymph node ratio in stage III colorectal cancer: a systematic review. Ann Surg Oncol. 2010;17:2847–55.PubMedCrossRefGoogle Scholar
  8. 8.
    Wang LP, Wang HY, Cao R, Zhu C, Wu XZ. Proposal of a new classification for stage III colorectal cancer based on the number and ratio of metastatic lymph nodes. World J Surg. 2013;37:1094–102.PubMedCrossRefGoogle Scholar
  9. 9.
    Govindarajan A, Baxter NN. Lymph node assessment: quality, not quantity. Ann Surg Oncol. 2013;20:3357–8.PubMedCrossRefGoogle Scholar
  10. 10.
    West NP, Kobayashi H, Takahashi K, Perrakis A, Weber K, Hohenberger W, et al. Understanding optimal colonic cancer surgery: comparison of Japanese D3 resection and European complete mesocolic excision with central vascular ligation. J Clin Oncol. 2012;30:1763–9.PubMedCrossRefGoogle Scholar
  11. 11.
    Kobayashi H, West NP, Takahashi K, Perrakis A, Weber K, Hohenberger W, et al. Quality of surgery for stage III colon cancer: comparison between England, Germany, and Japan. Ann Surg Oncol. 2014;21:S398–404. doi:  10.1245/s10434-014-3578-9.PubMedCrossRefGoogle Scholar
  12. 12.
    Akaike H. Information theory and an extension of the maximum likelihood principle. In: B.N. Petrov editor. Second International Symposium on Information Theory. Budapest: Akademiai Kiado; 1973:267–81.Google Scholar
  13. 13.
    Zhang J, Lv L, Ye Y, Jiang K, Shen Z, Wang S. Comparison of metastatic lymph node ratio staging system with the 7th AJCC system for colorectal cancer. J Cancer Res Clin Oncol. 2013;139:1947–53.PubMedCrossRefGoogle Scholar
  14. 14.
    Gunderson LL, Jessup JM, Sargent DJ, Greene FL, Stewart AK. Revised TN categorization for colon cancer based on national survival outcomes data. J Clin Oncol. 2010;28:264–71.PubMedCentralPubMedCrossRefGoogle Scholar
  15. 15.
    Gunderson LL, Jessup JM, Sargent DJ, Greene FL, Stewart A. Revised tumor and node categorization for rectal cancer based on surveillance, epidemiology, and end results and rectal pooled analysis outcomes. J Clin Oncol. 2010;28:256–63.PubMedCentralPubMedCrossRefGoogle Scholar
  16. 16.
    Wang J, Hassett JM, Dayton MT, Kulaylat MN. Lymph node ratio: role in the staging of node-positive colon cancer. Ann Surg Oncol. 2007;15:1600–8.CrossRefGoogle Scholar
  17. 17.
    Wang J, Kulaylat M, Rockette H, Hassett J, Rajput A, Dunn KB, et al. Should total number of lymph nodes be used as a quality of care measure for stage III colon cancer? Ann Surg. 2009;249:559–63.PubMedCrossRefGoogle Scholar
  18. 18.
    Moug SJ, Saldanha JD, McGregor JR, Balsitis M, Diament RH. Positive lymph node retrieval ratio optimizes patient staging in colorectal cancer. Br J Cancer. 2009;100:1530–3.PubMedCentralPubMedCrossRefGoogle Scholar
  19. 19.
    George S, Primrose J, Talbot R, Smith J, Mullee M, Bailey D, et al. Will Rogers revisited: prospective observational study of survival of 3592 patients with colorectal cancer according to number of nodes examined by pathologists. Br J Cancer. 2006;95:841–7.PubMedCentralPubMedCrossRefGoogle Scholar
  20. 20.
    Namm J, Ng M, Roy-Chowdhury S, Morgan JW, Lum SS, Wong JH. Quantitating the impact of stage migration on staging accuracy in colorectal cancer. J Am Coll Surg. 2008;207:882–7.PubMedCrossRefGoogle Scholar
  21. 21.
    Petrelli F, Borgonovo K, Barni S. The emerging issue of ratio of metastatic to resected lymph nodes in gastrointestinal cancers: an overview of literature. Eur J Surg Oncol. 2011;37:836–47.PubMedCrossRefGoogle Scholar
  22. 22.
    Kobayashi H, Mochizuki H, Kato T, Mori T, Kameoka S, Shirouzu K, et al. Lymph node ratio is a powerful prognostic index in patients with stage III distal rectal cancer: a Japanese multicenter study. Int J Colorectal Dis. 2011;26:891–6.PubMedCrossRefGoogle Scholar
  23. 23.
    Sugimoto K, Sakamoto K, Tomiki Y, Goto M, Kojima Y, Komiyama H. The validity of predicting prognosis by lymph node ratio in node-positive colon cancer. Dig Surg. 2013;30:368–74.PubMedCrossRefGoogle Scholar
  24. 24.
    Schiffmann L, Eiken AK, Gock M, Klar E. Is the lymph node ratio superior to the Union for International Cancer Control (UICC) TNM system in prognosis of colon cancer? World J Surg Oncol. 2013;11:79.PubMedCentralPubMedCrossRefGoogle Scholar
  25. 25.
    Priolli DG, Cardinalli IA, Pereira JA, Alfredo CH, Margarido NF, Martinez CA. Metastatic lymph node ratio as an independent prognostic variable in colorectal cancer: study of 113 patients. Tech Coloproctol. 2009;13:113–21.PubMedCrossRefGoogle Scholar
  26. 26.
    Vaccaro CA, Im V, Rossi GL, Quintana GO, Benati ML, Perez de Arenaza D, et al. Lymph node ratio as prognosis factor for colon cancer treated by colorectal surgeons. Dis Colon Rectum. 2009;52:1244–50.PubMedCrossRefGoogle Scholar
  27. 27.
    Schumacher P, Dineen S, Barnett C Jr, Fleming J, Anthony T. The metastatic lymph node ratio predicts survival in colon cancer. Am J Surg. 2007;194:827–31.PubMedCrossRefGoogle Scholar
  28. 28.
    Mori T. A comparison of the new (planned) TNM classification and Japanese general rule for staging colorectal cancer. Cancer Invest. 2010;28:387–92.PubMedCrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2014

Authors and Affiliations

  • Kiichi Sugimoto
    • 1
  • Kazuhiro Sakamoto
    • 1
  • Yuichi Tomiki
    • 1
  • Michitoshi Goto
    • 1
  • Kenjiro Kotake
    • 2
  • Kenichi Sugihara
    • 3
  1. 1.Department of Coloproctological SurgeryJuntendo University Faculty of MedicineTokyoJapan
  2. 2.Department of SurgeryTochigi Cancer CenterTochigiJapan
  3. 3.Department of Surgical Oncology, Graduate SchoolTokyo Medical and Dental UniversityTokyoJapan

Personalised recommendations